Updated
Updated · PR Newswire · Aug 7
Assaí Posts R$21.4 Billion Q2 Revenue as Leverage Falls to 2.37x
Updated
Updated · PR Newswire · Aug 7

Assaí Posts R$21.4 Billion Q2 Revenue as Leverage Falls to 2.37x

1 articles · Updated · PR Newswire · Aug 7

Summary

  • R$21.4 billion in Q2 gross revenue gave Assaí a 2.4% year-on-year increase, while recurring net income reached R$344 million and same-store market share rose 0.3 percentage point.
  • 3.4% higher customer traffic — topping 40 million monthly visits — and R$3.3 billion in operating cash generation helped push leverage down 0.8x over 12 months to its lowest level since Q3 2021.
  • R$2.7 billion in free cash flow over the last 12 months, combined with slower expansion and tighter capital allocation, underpinned the stronger balance sheet in a difficult macroeconomic environment.
  • 2026 growth initiatives also advanced: Assaí opened its first two Assaí Farma units in São Paulo, expanded supplements to 93 stores, launched 30 private-label items, and grew last-mile sales with iFood by 237%.

Insights

What hidden risks lie behind Assaí's rapid expansion into healthcare and private labels despite a brutal macroeconomic environment?
Can a traditional wholesaler successfully transform into a financial and healthcare powerhouse without losing its core price-sensitive customers?